The use of duloxetine in chronic bulimia nervosa: a case report.

Abstract

Selective serotonin reuptake inhibitors are routinely prescribed as off-label treatments for bulimia nervosa. There is, however, a paucity of literature addressing the efficacy of the serotonin norepinephrine reuptake inhibitors in the pharmacologic management of this disorder. This article describes a clinical situation in which duloxetine, a serotonin norepinephrine reuptake inhibitor, effectively treated a patient with long-standing bulimia nervosa, purging type, and comorbid generalized anxiety disorder.

• Authors: Richard C Christensen, Robert N Averbuch
• Journal: Psychiatry (Edgmont (Pa. : Township)) (Psychiatry (Edgmont)) Vol. 6 Issue 8 Pg. 27-8 (Aug 2009) ISSN: 1550-5952 [Print] United States
• PMID: 19763204 (Publication Type: Case Reports)